Clinical Trial Update: Limosilactobacillus Fermentum CRL 1446 - CONICET CASASCO [NA]

View source ↗

Summary

A clinical trial update indicates ongoing investigation of the probiotic Limosilactobacillus fermentum CRL 1446 for obesity and related metabolic conditions; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hyperlipidemia
• Hypertension
• Obesity

Drugs mentioned

• Limosilactobacillus fermentum CRL 1446

Snippet

Sponsor: PINER Pastor Manfredi Winery | Conditions: Disbiosis, Obesity | NA | Status: ACTIVE_NOT_RECRUITING